LCM
Lynx1 Capital Management Portfolio holdings
AUM
$346M
This Quarter Return
+29.78%
1 Year Return
-2.97%
3 Year Return
+1,498.67%
5 Year Return
–
10 Year Return
–
AUM
$115M
AUM Growth
–
Cap. Flow
+$115M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
10
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Merus
MRUS
|
$24.9M |
| 2 |
Travere Therapeutics
TVTX
|
$22.9M |
| 3 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$17.5M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$16.1M |
| 5 |
IMGN
Immunogen Inc
IMGN
|
$15.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merus
MRUS
$4.98B
| $24.9M | 21.74% |
+783,398
| New | +$24.9M |
|
|
2
Travere Therapeutics
TVTX
$1.56B
| $22.9M | 19.96% |
+737,061
| New | +$22.9M |
|
|
ALPN
3
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $17.5M | 15.25% |
+1,261,927
| New | +$17.5M |
|
|
BLU
4
DELISTED
BELLUS Health Inc.
BLU
| $16.1M | 14.07% |
+2,003,114
| New | +$16.1M |
|
|
IMGN
5
DELISTED
Immunogen Inc
IMGN
| $15.8M | 13.79% |
+2,129,531
| New | +$15.8M |
|
|
PRDS
6
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $6.57M | 5.74% |
+401,593
| New | +$6.57M |
|
|
THRX
7
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.19M | 4.53% |
+409,358
| New | +$5.19M |
|
|
CBAY
8
DELISTED
Cymabay Therapeutics
CBAY
| $4.14M | 3.61% |
+1,224,968
| New | +$4.14M |
|
|
PVLA
9
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
| $1.45M | 1.26% |
+383,266
| New | +$1.45M |
|
|
OTIC
10
DELISTED
Otonomy, Inc.
OTIC
| $62K | 0.05% |
+30,000
| New | +$62K |
|